BG Medicine Inc (CE) (BGMD) ニュース

Veravas?

Is this company finally shut down?

Here is to the beginning of the beginning!!
Via! Vai! Vai!
Over a buck!!!! Minimum

ummmm.....nope...bought on the market, definitely not an insider....if I had to guess, I'd guess you're wrong a lot.....

If I were to guess...I’d guess someone gave you an opportunity you thought had no risk, just patience.
You took the last non management associates 10%+ position that was liquidated and shorted down....

If you did that?
You will eventually be prosecuted for insider trading....
But that should be the least of your worries! As you might be given THE “I’m broke” free pass!
All your invited participants and associates will crash (not crumble)...

Ps...change your avatar to somebodytoldme!!!!

Being an insider doesn’t effect predictions...it could just get you in jail.
I’ve done my work...
I’m very comfortable with my position and timeline...
It’s not luck

unless you're an insider with information not generally available, then I doubt seriously that will happen.......the company went dark-actually filed paperwork with the sec and filed appropriate public notices that they were going to do that.....glty

Anybody want to bet we see 1.25+ within 2 years max?
Such a difficult thought process for short term mindsetters.....
It’s a reality ; to identify and separate what is what and what isn’t what what isn’t...

I saw something here to reaffirm my convictions.
Be patient

This old article just gives an interesting and detailed insight (apparently the last one) into BGMD's business activities about 5 months before they went dark.

That's a 2015 article....company is dark, and has been for awhile....used shareholder money to get their product developed and to market, then went dark....

https://seekingalpha.com/article/3730236-bg-medicine-nearing-finish-line

Thanks for the link and your posts Bertbex. I still have shares from years ago that I wrote off. Maybe now they may come out of the "Dark"!

Would this utilize the bgmd test on the Abbot equipment? I know they have the FDA clearance for heart failure testing but would they have to get another FDA approval for bgmd to benefit from covid testing. Wow, things might be looking up.

When you google „galectin-3 corona“, you will find:

https://www.news-medical.net/amp/news/20210210/Could-Galectin-3-be-a-potential-biomarker-to-help-identify-severe-COVID-19-early.aspx

There even exist instructions for "Going Dark - Voluntary Delisting and Deregistration...“ (with pros and cons) when you google „15-12B pink sheets", for example:

https://www.dorsey.com/newsresources/publications/2009/03/going-dark--voluntary-delisting-and-deregistrati__

With SEC in the public sights. There will inevitably be some movement in quite a few quiet equities for reasons that will ....eventually .....become public....

For some it will be good to great depending on which side you sit....
And for others terrible or worse depending on where you sit....

@ThirdSyte: Thanks for reminding us about their filed 15-12B on 05/05/2016 (otc.com, BGMD, Disclosure). This explains that BGMD's behavior (to report nothing) is apparently legal.

They filed a 15-12b in May of 2016.

As an "Alternate Reporting" company trading on the Pink Sheets, the filing removes their obligation to report anything.

It also prevents the SEC from suspending them for no filings.

I can't believe I hold a stock where they can legally keep revenue info from share owners. Good luck, maybe a long shot but might be the only shot, or a lawsuit.

Email to the SEC: Yesterday (Wed, Feb. 10, 2021) I sent the following email to "boston@sec.gov" (The Boston Regional Office of the U.S. Securities and Exchange Commission"):

"Dear Sir or Madam,

if you request financial compensation for processing this request, please let me know before further processing!

I am a retail investor in BG Medicine (BGMD) based in Foxborough, MA (http://bg-medicine.com) whose chairman is Craig Jalbert (Verdolino & Lowey, PC Foxborough, MA) since July 26, 2018. On July 09, 2015 a 1 for 4 split was carried out, and on Sept. 16, 2015 the delisting from Nasdaq took place (https://www.otcmarkets.com/stock/BGMD/security). Since then, BG Medicine is traded on OTC pink sheets as "BGMD".

The big issue is (for retail investors like me) why since June 27, 2016 there have been no official publications any more from BGMD like operating business results? (see the last disclosures at https://www.otcmarkets.com/stock/BGMD/disclosure). Why they disclose at least no unaudited operating results? By the way, BGMD´s share price has risen again significantly since December 2020.

So is BGMD not violating against any laws by going dark intentionally?


I have collected the following information about BGMD:

- The answer below in this email trail from Craig Jalbert on Nov. 16, 2020: “…There is no reporting of any kind to anyone nor will there ever be.”

- The answer below in this email trail from Mary Jo Schindler Bailey on July 01, 2020 (her email address is shown when you click on “email us” at BGMD´s website “contact us”): "To recap BG’s status, on July 26, 2018, pursuant to Section 141(f) of the General Corporation Law of the State of Delaware, the directors of BG Medicine, Inc., appointed Craig R. Jalbert, as Chairman, Chief Executive Officer, President, Chief Financial Officer, Treasurer and Secretary of the Corporation, to serve in accordance with the company’s Bylaws, and to manage the company’s business affairs going forward. The former BG Board of Directors resigned at that time. The company continues to operate, as having entered in to several manufacturing and sales agreements with several partners. With that said, the company is limping along right now. There is no bankruptcy, and not much else to report at this time.”

- BGMD has withdrawn their new drug application on Dec. 23, 2015: https://www.globenewswire.com/news-release/2015/12/23/797949/0/en/BG-Medicine-Withdraws-510-k-Premarket-Notification-for-Proposed-Additional-Indication-for-the-BGM-Galectin-3-Test.html

- BGMD maybe paid back their debts: https://www.gurufocus.com/term/deb2equity/BGMD/Debt-to-Equity/BG%2BMedicine%2BInc

- BGMD has obviously a patent in processing: https://patents.google.com/patent/US20200033367A1/en

- BGMD obviously paid a scientist: "See at footnotes: "Dr. Cappola has received research funding from BG Medicine.": https://www.sciencedirect.com/science/article/abs/pii/S2213177919308005

- According to https://www.otcmarkets.com/stock/BGMD/security there might be still a major shareholder who owns 1,979,380 shares, because this number of shares results in the difference between 11,374,360 outstanding shares (Dec. 19, 2018) and float of 9,394,980 shares (Sept. 15, 2015). Perhaps this could be a reason for a dispute in how to lead the company? (More information about BGMD´s current share ownership is available at https://fintel.io/so/us/bgmd if still correct?)


I would be glad to get an answer from you.
With Best Regards

XXXX YYYYYYY
Address: zzz
Tel. mobile: zzz
Email: zzz"

(If I will get an answer from the SEC, I will publish it here on Investorshub)

Once going dark law is 10%

My understanding of the law, any investor whether owning 1 share or 1 million shares has the right to the companies tax returns.

Might want to get this to Reddit about market maker relentlessly shorting stock for two years

I wanted to post the following email on the Yahoo Finance Message Board of BGMD, but it didn't work. So I post it here: On Jan. 12, 2021, I sent this email to a law firm (I will inform you if I will get further replies, your suggestions are welcome):

“Dear Sir or Madam,

I chose you to contact by using the website https://www.lawinfo.com/class-action/massachusetts/foxborough/. If you or other advisors request financial compensation for processing this request, please let me know before further processing!

I am a retail investor in BG Medicine (BGMD) based in Foxborough, MA (http://bg-medicine.com) whose chairman is Craig Jalbert (Verdolino & Lowey, PC Foxborough, MA) since July 26, 2018. It seemed that BGMD got financial problems in 2015: On July 09, 2015 a 1 for 4 split was carried out, and on Sept. 16, 2015 the delisting from Nasdaq took place (https://www.otcmarkets.com/stock/BGMD/security). Since then, BG Medicine is traded on OTC pink sheets as "BGMD".

The big issue is (for retail investors like me) why since June 27, 2016 there have been no official publications any more from BGMD like operating business results? (see the last disclosures at https://www.otcmarkets.com/stock/BGMD/disclosure) Because to save money? Why they disclose at least no unaudited operating results?

So I suggest a class action lawsuit should be filed with the aim of forcing BGMD to publish at least unaudited operating results! By the way, BGMD´s share price has risen again significantly since December 2020.

The only way to get information about BGMD are discussion forums at the Yahoo Finance Message Board of BGMD (https://finance.yahoo.com/quote/BGMD/community/) and at Investorshub (https://investorshub.advfn.com/BG-Medicine-Inc-BGMD-24164/). Some people speculate that BGMD's products and patents might be worth significantly more than the current low market capitalization (https://www.otcmarkets.com/stock/BGMD/security). I have collected the following information about BGMD since June 27, 2016:

- The answer below from Craig Jalbert on Nov. 16, 2020: “…There is no reporting of any kind to anyone nor will there ever be.”

- The answer below from Mary Jo Schindler Bailey on July 01, 2020 (her email address is shown when you click on “email us” at BGMD´s website “contact us”): "To recap BG’s status, on July 26, 2018, pursuant to Section 141(f) of the General Corporation Law of the State of Delaware, the directors of BG Medicine, Inc., appointed Craig R. Jalbert, as Chairman, Chief Executive Officer, President, Chief Financial Officer, Treasurer and Secretary of the Corporation, to serve in accordance with the company’s Bylaws, and to manage the company’s business affairs going forward. The former BG Board of Directors resigned at that time. The company continues to operate, as having entered in to several manufacturing and sales agreements with several partners. With that said, the company is limping along right now. There is no bankruptcy, and not much else to report at this time.”

- BGMD has obviously a patent in processing (January 30, 2020). The corresponding link was published at yahoo message board of BGMD: https://patents.google.com/patent/US20200033367A1/en

- BGMD obviously paid a scientist (March 08, 2020): "Footnotes: Dr. Cappola has received research funding from BG Medicine." The corresponding link was published at yahoo message board of BGMD: https://www.jacc.org/doi/full/10.1016/j.jchf.2019.09.009

- According to https://www.otcmarkets.com/stock/BGMD/security there might be still a major shareholder who owns 1,979,380 shares, because this number of shares results in the difference between 11,374,360 outstanding shares (Dec. 19, 2018) and float of 9,394,980 shares (Sept. 15, 2015). Perhaps this could be a reason for a dispute in how to lead the company? (More information about BGMD´s current share ownership is available at https://fintel.io/so/us/bgmd if still correct)

I am German citizen. My occupation is engineer (currently unemployed). I don't have any inside knowledge about BGMD, because I don't know anyone who works or ever worked at BGMD and I never had any business or any work relationship with BGMD, nor I got ever in touch with their products.

I myself bought 91,000 shares of BGMD in 2014 and 2015 (I spent at least € 58,199.14 or even more). On July 09, 2015 (day of 1 for 4 split) my shares were converted into 22,750 shares. Then I bought more 479,250 shares from 2017 to 2019 and thus I own totally 502,000 shares which are approx. 4.4% of all outstanding shares. Maybe it might be useful to increase my stake to over 5% in order to force BGMD to disclose information to me as shareholder?

I asked my bank what happened in case of increasing my stake to more than 5%? They replied me on Aug. 17, 2018: "Basically, with foreign shares, it is not you who are personally recorded in the share register, but your bank as the custodian bank. If there is actually a reportable process according to Schedule 13 D, it is not you who are initially required to report, but your bank. If necessary, we would approach you again.”

I would be happy to hear from you whether it may be promising to file a class action against BGMD or not? You could initiate this or alternatively forward this email to other advisors or you (or other advisors) are also welcome to publish suggestions on the Yahoo Finance Message Board of BGMD, but in case please only mention my alias name “Bertbex” which I use to communicate there for reasons of discretion (please do not publish my real name XXXX YYYYYYY!).

With Best Regards
XXXX YYYYYYY”

I published (on the yahoo message board of BGMD) on July 01, 2020:

BGMD has a modified website since last week. When you want to contact the company, you get the email address of Mary Jo Schindler. I asked her: "Can you give me information about what´s going on with BGMD? Are you BGMD´s bunkruptcy councel or only their new accountant or manager?"

She answered me today: "To recap BG’s status, on July 26, 2018, pursuant to Section 141(f) of the General Corporation Law of the State of Delaware, the directors of BG Medicine, Inc., appointed Craig R. Jalbert, as Chairman, Chief Executive Officer, President, Chief Financial Officer, Treasurer and Secretary of the Corporation, to serve in accordance with the company’s Bylaws, and to manage the company’s business affairs going forward. The former BG Board of Directors resigned at that time. The company continues to operate, as having entered in to several manufacturing and sales agreements with several partners. With that said, the company is limping along right now. There is no bankruptcy, and not much else to report at this time.

Thank you,
Mary Jo

Mary Jo Schindler Bailey
Verdolino & Lowey, P.C.
Certified Public Accountants
124 Washington Street, Suite 101
Foxborough, MA 02035
P 508-543-1720
F 508-543-4114"


On Nov. 05, 2020, I replied to her (mjschindler@vlpc.com): “Dear Mary Jo, thank you for your answer. Why is no further information, such as unaudited annual results available or published? Is it not permitted by law, or does the former management not want it (e.g. a higher share price) or would the effort cost too much money which BGMD does not have? Can you answer this question? Kind Regards XXXX YYYYYYY“


On Nov. 15, 2020, I forwarded this email above to Craig R. Jalbert. On Nov. 16, 2020, Craig replied to me: “I’m sorry that we missed your 11/15 e-mail. If you follow the trail below, you received a message from MJ on 7/1/2020. Nothing has changed. There is no reporting of any kind to anyone nor will there ever be. Sorry. Be safe.

Craig R. Jalbert, CIRA
Verdolino & Lowey. P.C.
124 Washington Street, Suite 101
Foxboro, MA 02035
Phone - 508-543-1720
Fax - 508-543-4114
Mobile - 508-889-1990
cjalbert@vlpc.com“

More big bids of 250K showed up at .041 so something is cooking here. I believe there is a big short and this things is going to pop. No size showed up until today at .07 for 23K shares. No real size until .17 which has 49K there. Could be a squeeze early next year.

Today there was a 250K bid at .0401. Lots of volume today seems like there is a short squeeze. Found this article that showed that Galectin-3 serum was a prognosticator of severe covid-19.

https://www.medrxiv.org/content/10.1101/2020.11.13.20231209v1

There are a whole bunch more articles that show demand for the test will go up.

Huge Spread Offered at .18 and big 150K bid. Wheres the float on this? massive low floater. Could go up huge.

From the Yahoo BGMD board (good news)

BGMD has a modified website since last week. When you want to contact the company, you get the email address of Mary Jo Schindler. I asked her: "Can you give me information about what´s going on with BGMD? Are you BGMD´s bunkruptcy councel or only their new accountant or manager?"

She answered me today: "To recap BG’s status, on July 26, 2018, pursuant to Section 141(f) of the General Corporation Law of the State of Delaware, the directors of BG Medicine, Inc., appointed Craig R. Jalbert, as Chairman, Chief Executive Officer, President, Chief Financial Officer, Treasurer and Secretary of the Corporation, to serve in accordance with the company’s Bylaws, and to manage the company’s business affairs going forward. The former BG Board of Directors resigned at that time. The company continues to operate, as having entered in to several manufacturing and sales agreements with several partners. With that said, the company is limping along right now. There is no bankruptcy, and not much else to report at this time.

Thank you,
Mary Jo

Mary Jo Schindler Bailey
Verdolino & Lowey, P.C.
Certified Public Accountants
124 Washington Street, Suite 101
Foxborough, MA 02035
P 508-543-1720
F 508-543-4114"

Might actually sell some tests now that cov -19 linked to heart issues.

Galectin-3 test-Architect i 2000srAbbott and VIDAS® bioMerieux.
BGMD Mkt cup 420 000$

agree about the patents! management is scum though, and wouldn't surprise me if they set themselves up as creditors, filed bk, and scooped up the patents for themselves.

just my opinion, of course

glta!

The patents of BGMD have to be worth more than this company is on the dark paper. Just hope those of us who hung on will see some of it.

Galectin-3 predicts response and outcomes after cardiac resynchronization therapy.https://www.ncbi.nlm.nih.gov/pubmed/30390680

In the Emergency Department, accurate diagnosis in a minimum of time is critical to ensure the best patient outcomes.https://www.biomerieux-diagnostics.com/emergency-department-patient-management https://www2.cscc.unc.edu/aric/node/9824 https://onlinelibrary.wiley.com/doi/full/10.1002/rth2.12038

https://www.accessdata.fda.gov/cdrh_docs/pdf14/K140436.pdf

70th AACC Annual Scientific Meeting Abstracts, 2018. Race- and Sex- Dependent Association of BNP and Galectin-3 Levels
with 6-Month All-Cause Mortality in Patients with Elevated BNP.
file:///C:/Users/asus/Downloads/A65A113%20(4).pdf

Ya it doesn't make much sense, especially with the 60k shares traded yesterday (.5% of total shares)

There's a few possibilities

1. somebody knows something
2. residual speculation based on message board posts from 3 years ago
3. trading based on expected post-bankruptcy valuation ( 1 - 15 million?)

What doesn't make sense is that nothing has been filed *anywhere* since August concerning bankruptcy, including delaware, federal, and massachusetts bankruptcy courts. So the Jalvert transfer timing doesn't make sense since they don't seem to be moving fast on it since the transfer.

But something seems like it is going to give soon maybe by the end of this year, so this saga can end one way or the other..

Why is there any shares trading on this? It makes no sense.

The Predictive Value of Plasma Brain Natriuretic
Peptide and Galectin-3 in Elderly Patients Admitted
for Heart Failure file:///C:/Users/asus/Downloads/diseases-06-00088.pdf
https://www.ncbi.nlm.nih.gov/pubmed/30262779

Great article it shows the importance of the test we have all believed in. Now the question is what is done with the patents and knowledge? Liquidation to the highest bidder? Will we see any of it?

Galectin-3 Reflects the Echocardiographic Grades of Left Ventricular Diastolic Dysfunction.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895859/

http://corp.sec.state.ma.us/corpweb/CorpSearch/CorpSearch.aspx and BG Medicine as search term, it's all there...what you conclude from it all is another story..

@nml12: Where can I find the details you wrote about?

Thanks for the info--I hate to hear it, too!

This company has a valid patent of worth--poor management did it in, imo. Champagne taste/beer pocketbook. You can bet they did well, though.

glta

***********************************************************
just my opinions, of course

Looks like this is going bye bye. I am an investor and did some research just now. Massachusetts corporate filings show that last month BGMD changed their address of record to an office in address in Foxborough, and changed the registered agent to a Craig Jalbert, and also made him President, Treasurer, and Secretary. Craig Jalbert is an experienced bankruptcy attorney. Of the 10 or so companies he is registered as president of in the state of Massachusetts, 5 are biotech companies, and 4 are defunct with 1 being bought out. So it looks like he is the hired undertaker of failed companies. Also last month Paul Sohmer removed his picture from his Linkedin profile...:D I think this is wrapping up real soon, unfortunately.

On OTC Markets this is a Pink--no information stock....not good at all.....watch the trade volume--not much!

Also has a warning on the main overview screen: Warning! This company may not be making material information publicly available

These are not things that I want to see when considering the purchase of a stock, or in a stock I own....and unfortunately I do own some of this.

glta!

********************************************************
just my opinions, of course

https://www.otcmarkets.com/stock/BGMD/security

What? Could you explain more for us slow ones?